Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

Author： Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.84, Iss.2, 2004-03, pp. : 173-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells

By        

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 867-872

Spandidos Publications

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Prospects of Radioimmunotherapy in Epithelial Ovarian Cancer: Results with Iodine-131-Labeled Murine and Humanized MN-14 Anti-carcinoembryonic Antigen Monoclonal Antibodies

By Juweid M.   Swayne L.C.   Sharkey R.M.   Dunn R.   Rubin A.D.   Herskovic T.   Goldenberg D.M.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 259-271

Elsevier

Access to resources Recommend Favorite

Conjugation of interferon alpha to a humanized monoclonal antibody (HuBrE-3vl) enhances the selective localization and antitumor effects of interferon in breast cancer xenografts

By Ozzello L.  

Breast Cancer Research and Treatment, Vol. 48, Iss. 2, 1998-03 ,pp. : 135-147

Springer Publishing Company

Access to resources Recommend Favorite

Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite